Furthermore, no clinical or neuroimaging data can clearly predict neuropathological trait in FTD patients without pathogenic mutations, and it is unknown whether Tau and TDP43 unfolding represents the primary pathogenic mechanism or whether this might be triggered by external and still undetermined factors. This evidence concerns the gene MAPT and frontotemporal dementia.